Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy

R Zatz, T W Meyer, H G Rennke, B M Brenner, R Zatz, T W Meyer, H G Rennke, B M Brenner

Abstract

Six groups of Munich-Wistar rats underwent micropuncture study 2-10 weeks and morphologic studies 11-13 months after induction of streptozotocin diabetes or after sham treatment. Diabetic rats received diets containing 6% (group D6), 12% (D12), or 50% protein (D50) and were maintained under similar conditions of moderate hyperglycemia by daily injections of ultralente insulin. Age- and weight-matched normal control rats were also given 6% (Group N6), 12% (N12), or 50% protein (N50). Kidney weight, whole-kidney and single-nephron glomerular filtration rate, glomerular plasma flow, and mean glomerular transcapillary hydraulic pressure difference were higher in D50 rats than in all other groups and predisposed this group to marked and progressive albuminuria. Likewise, histological examination of the kidneys disclosed areas of sclerosis in 19.6% of glomeruli in D50 rats; the frequency of such lesions was less than 2.5% in all other groups. These findings indicate that the metabolic disorder seen in stable, moderately hyperglycemic diabetic rats does not lead to glomerulopathy as long as elevations in glomerular pressures and flows are prevented.

References

    1. Immunochemistry. 1965 Sep;2(3):235-54
    1. Ann Paediatr. 1959 Sep;193:129-38
    1. Acta Med Scand. 1973 Jul-Aug;1-2(1):31-7
    1. Am J Pathol. 1975 Apr;79(1):95-106
    1. Kidney Int. 1975 Jun;7(6):397-404
    1. Am J Physiol. 1976 Apr;230(4):1148-58
    1. Am J Pathol. 1976 Nov;85(2):277-302
    1. Diabetes. 1978 Jan;27(1):35-41
    1. Kidney Int. 1977 Nov;12(5):332-43
    1. Diabetes. 1978 Jul;27(7):738-44
    1. Anal Biochem. 1978 Aug 1;88(2):513-21
    1. Diabetologia. 1979 Mar;16(3):185-90
    1. J Lab Clin Med. 1979 Jun;93(6):950-61
    1. J Clin Invest. 1980 May;65(5):982-8
    1. Lancet. 1980 Apr 5;1(8171):738-40
    1. Circ Res. 1980 Jul;47(1):1-9
    1. Am J Physiol. 1980 Dec;239(6):E412-21
    1. Acta Endocrinol Suppl (Copenh). 1981;242:11-3
    1. Diabetologia. 1981 Apr;20(4):451-6
    1. Kidney Int. 1981 Mar;19(3):410-5
    1. Am J Physiol. 1981 Jul;241(1):F85-93
    1. Diabetologia. 1981 Oct;21(4):409-14
    1. J Lab Clin Med. 1981 Dec;98(6):869-85
    1. Am J Med. 1982 Mar;72(3):375-80
    1. Eur J Clin Invest. 1981 Dec;11(6):487-90
    1. Kidney Int. 1982 May;21(5):683-8
    1. N Engl J Med. 1982 Sep 9;307(11):652-9
    1. Kidney Int. 1982 Aug;22(2):112-26
    1. Diabetologia. 1982 Dec;23(6):485-7
    1. J Clin Invest. 1983 May;71(5):1062-72
    1. Prostaglandins Leukot Med. 1983 Aug;11(4):431-42
    1. Diabetologia. 1984 Feb;26(2):93-8
    1. J Clin Invest. 1984 May;73(5):1448-61
    1. Am J Physiol. 1984 Jul;247(1 Pt 2):F110-6
    1. J Clin Invest. 1985 Feb;75(2):404-12
    1. Kidney Int. 1983 Apr;23(4):643-6
    1. Scand J Clin Lab Invest. 1971 Sep;28(1):91-100

Source: PubMed

3
Prenumerera